Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression
Arief Wibowo, Raymond Pranata, Mohammad Rizki Akbar, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 312-318
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update
Yousef Rasmi, Osama F. Mosa, Shahriar Alipour, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 8
Dose response relationship between D-dimer level and mortality in critically ill COVID-19 patients: a retrospective observational study
Dita Aditianingsih, Ratna Farida Soenarto, Artheta Mutiara Puiantana, et al.
F1000Research (2023) Vol. 11, pp. 269-269
Open Access | Times Cited: 4
Cardiac Troponin-I and COVID-19: a prognostic tool for in-hospital mortality
Hany William, Randa Salam, Mohamed Mamdouh Youssef, et al.
Alexandria Journal of Medicine (2023) Vol. 59, Iss. 1, pp. 59-67
Open Access | Times Cited: 4
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer?
Renato de Falco, Maria Vargas, Daniela De Palma, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2726-2726
Open Access | Times Cited: 11
Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
Antonia Anna Lukito, Allen Widysanto, Theo Audi Yanto Lemuel, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 159-166
Open Access | Times Cited: 10
Nanocurcumin formulation: a possible therapeutic agent for post COVID inflammatory syndrome
Asha D. Kushwaha, K.P. Mishra, Mrinalini Singh, et al.
Immunopharmacology and Immunotoxicology (2022) Vol. 44, Iss. 2, pp. 141-146
Closed Access | Times Cited: 6
Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction
Katarzyna Gryglewska-Wawrzak, Agata Sakowicz, Maciej Banach, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 4160-4160
Open Access | Times Cited: 3
The COVID-19 Pandemic and Coronary Heart Disease: the Next Surge
Asim Shaikh, Sarim Dawar Khan, Farhala Baloch, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 9, pp. 559-569
Closed Access | Times Cited: 3
The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence
Iordanis Mourouzis, Vassiliki Apostolaki, Athanasios Trikas, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 8063-8063
Open Access | Times Cited: 5
Urban–Rural Differences in Health Care Utilization and COVID-19 Outcomes in Patients With Type 2 Diabetes
Annemarie G. Hirsch, Cara Nordberg, Karen Bandeen‐Roche, et al.
Preventing Chronic Disease (2022) Vol. 19
Open Access | Times Cited: 5
Prediction of the need for intensive oxygen supplementation during hospitalisation among subjects with COVID-19 admitted to an academic health system in Texas: a retrospective cohort study and multivariable regression model
John W. Davis, Beilin Wang, Ewa Tomczak, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e058238-e058238
Open Access | Times Cited: 4
Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data
Lara Chammas, Kevin Yuan, Stephanie Little, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Key role of laboratory diagnostics of cardiovascular system injury in COVID‑19
Serafima Ya. Tazina, I. Y. Antipova, Т. А. Федорова, et al.
Medical alphabet (2024), Iss. 20, pp. 26-32
Closed Access
COVID-19 Pathophysiology: Inflammation to Cardiac Injury
Sami Fouda, Robert Hammond, Peter Donnelly, et al.
Hearts (2024) Vol. 5, Iss. 4, pp. 628-644
Open Access
Impact on clinical guideline adherence of Orient-COVID, a clinical decision support system based on dynamic decision trees for COVID19 management: a randomized simulation trial with medical trainees
M. Jammal, Antoine Saab, Cynthia Abi Khalil, et al.
International Journal of Medical Informatics (2024) Vol. 195, pp. 105772-105772
Open Access
Troponin Levels in COVID-19 Patients and its Correlation with the Severity of Disease and Clinical Outcomes
Vaibhav Shukla, Advait Munagekar
Indian Journal of Medical Specialities (2022) Vol. 13, Iss. 1, pp. 41-44
Closed Access | Times Cited: 3
Utility of Cardiac Troponin-I in the Prediction of In-Hospital Mortality of Patients With COVID-19: A Retrospective Cohort Study in Central India
Himanika Paliwal, Nadia Noor Ali, Abhijit Ninghot, et al.
Cureus (2024)
Open Access
Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation
Chukwuemeka Umeh, Heather Maoz, Jessica Obi, et al.
World Journal of Cardiology (2023) Vol. 15, Iss. 9, pp. 427-438
Open Access | Times Cited: 1
Quantification of hs-Troponin Level and Global Longitudinal Strain among Critical COVID-19 Patients with Myocardial Involvement
Mochamad Yusuf Alsagaff, Louisa Fadjri Kusuma Wardhani, Ricardo Adrian Nugraha, et al.
(2023)
Open Access | Times Cited: 1
Dose response relationship between D-dimer level and mortality in critically ill COVID-19 patients: a retrospective observational study
Dita Aditianingsih, Ratna Farida Soenarto, Artheta Mutiara Puiantana, et al.
F1000Research (2022) Vol. 11, pp. 269-269
Open Access | Times Cited: 1
Cardiac Injury in COVID-19: A Systematic Review of Relevant Meta-Analyses
Konstantinos G. Kyriakoulis, Ioannis Kyriakoulis, Ioannis Trontzas, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 12, pp. 404-404
Open Access | Times Cited: 1
COVID-19 and Cardiovascular Complications: An Updated Review
Januar Wibawa Martha
Open Access Macedonian Journal of Medical Sciences (2021) Vol. 9, Iss. F, pp. 712-719
Open Access | Times Cited: 1
High-sensitive troponin-T as a predictive outcome factor in COVID-19 hospitalised patients: Analysis after one-year follow-up
Darko Stojanović, Živko Ćetojević, Boris Dujaković, et al.
SCRIPTA MEDICA (2021) Vol. 52, Iss. 2, pp. 96-103
Open Access | Times Cited: 1
Atteintes myocardiques au cours de la Covid-19, utilité des biomarqueurs cardiaques
Carole Émile
Option/Bio (2023) Vol. 34, Iss. 665-666, pp. 24-25
Open Access
No Evidence for Myocarditis or Other Organ Affection by Induction of an Immune Response against Critical SARS-CoV-2 Protein Epitopes in a Mouse Model Susceptible for Autoimmunity
Rebecca Maria Ignatz, Vanessa Antje Zirkenbach, Mansur Kaya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9873-9873
Open Access

Scroll to top